Purchase Order 75N92023P00298
Award Date 8/29/23
Potential Completion Date 8/28/24
Potential Value $53K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Morrisville, NC, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $118,993 firm fixed price purchase order to Metabolon, Inc. to conduct research analyzing the metabolomic profile associated with cardiometabolic traits in African Americans. The contract has a period of performance from August 29, 2023 through August 28, 2024. Under the solicitation seeking this analysis, Metabolon will leverage its expertise in metabolomics to provide...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $177,991.20 firm fixed price purchase order to Metabolon, Inc., a self-certified small disadvantaged business, for metabolomic profiling of individuals of African descent. The order was issued directly under a solicitation, without the use of a set-aside. Metabolon provides metabolomics services and solutions to government agencies, leveraging its proprietary technology...
- Metabolon, Inc., a small disadvantaged business, was awarded a $244,993.28 firm fixed price purchase order by the National Institutes of Health's National Human Genome Research Institute. The purpose is to perform metabolomic profiling of individuals of African descent with metabolic disorders, including a focus on comparing the metabolic profiles of those with high versus low triglyceride levels. This award is part of the Africa America Diabetes study and aims to integrate multiple omics...
- The National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), awarded a $52,806 firm fixed-price purchase order to Metabolon, Inc. for Genomic Sample Study Analysis Services. The award, issued on September 12, 2025, with an ultimate completion date of September 11, 2026, represents a new contract without set-aside designation, making it available through full and open competition. Services will be performed in Bethesda, Maryland, with work to be...
- This is a firm fixed price purchase order contract awarded to Metabolon, Inc., a small disadvantaged business, by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute. The $279,378 contract is to provide metabolomics services to support the GENEFORECAST, SIT, and MHGRID research projects. Metabolon is an experienced provider of specialized metabolomics analysis capabilities for the federal government, having supported numerous...
- Metabolon, Inc. was awarded a $44,775 purchase order contract by the National Institutes of Health's National Institute of Diabetes and Digestive and Kidney Diseases to provide unspecified services or products. The contract is a firm fixed price agreement that will be performed in Research Triangle Park, North Carolina over approximately 15 months from February 2018 through May 2019. No additional details were provided regarding the original solicitation or scope of work. Metabolon, Inc. is...
- This is a $112,030.00 firm-fixed-price delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Metabolon, Inc., a self-certified small disadvantaged business. The contract is for a prospective investigation of microbial metabolites, bile acids, and short-chain fatty acids in relation to colorectal cancer, as part of the ATBC Prevention Study. The work will be performed in Durham, North Carolina. Metabolon provides...
- The NIH Clinical Center awarded a $24,784 firm fixed-price purchase order to Metabolon, Inc. for metabolomics analysis services. The contract, which commenced on September 9, 2025, with an ultimate completion date of September 8, 2026, represents a task order under Metabolon's existing Indefinite Delivery Contract with the NIH Clinical Center valued at $250,000. No set-aside designation was utilized for this award. Metabolon, a self-certified small disadvantaged business headquartered in...
- This is a delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Metabolon, Inc., a self-certified small disadvantaged business. The $178,815.00 contract is for the investigation of microbial metabolites, bile acids, and short-chain fatty acids in relation to colorectal cancer, adenoma, and diet. The work falls under the Major Program Code "METABOLOMIC PROFILING FOR MOLECULAR EPIDEMIOLOGY STUDIES."...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health's National Human Genome Research Institute to Metabolon, Inc., a small disadvantaged business, for the purpose of discovering diabetes metabolomics biomarkers in plasma and tissue samples from the NHGRI Fusion cohort clinical study, including meta-analysis with the METSIM cohort. The potential value of the contract is USD 376,105.00, with a completion date of May 29, 2019. Metabolon is a provider of...